4//SEC Filing
Pare Anthony 4
Accession 0000899243-21-011891
CIK 0001492674other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 12:41 PM ET
Size
7.3 KB
Accession
0000899243-21-011891
Insider Transaction Report
Form 4
Pare Anthony
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-03-14+17,500→ 41,232 total - Exercise/Conversion
Restricted Stock Units
2021-03-14−17,500→ 35,000 total→ Common Stock (17,500 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 15,206 shares acquired under the Issuer's employee stock purchase plan on May 15, 2020 (the "ESPP") and 3,949 shares acquired under the ESPP on November 15, 2020.
- [F3]On March 14, 2020 the reporting person was granted 52,500 RSU's that vest in three equal annual installments beginning on March 14, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001418863
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 12:41 PM ET
- Size
- 7.3 KB